Press release
North America SGLT2 Inhibitors Market Expected to Reach USD 16.37 Billion by 2034, Growing at an 8.4% CAGR
North America SGLT2 Inhibitors Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide North America SGLT2 inhibitors market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by indication, drug, distribution channel, and country in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/north-america-sglt2-inhibitors-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
SGLT2 inhibitors are an innovative type of diabetes drugs that assist the body in managing blood glucose levels. Their function is to inhibit the activity of SGLT2, a protein that facilitates the transportation of glucose from the blood to the cells. Blocking SGLT2 results in a decrease in the body's sugar absorption caused by these medications.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐๐๐๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
By drug, in 2024, the Jardiance (Empagliflozin) segment accounted for the largest revenue share of the North America SGLT2 inhibitors market. Jardiance's robust clinical profile demonstrates significant benefits in reducing cardiovascular mortality and heart failure hospitalizations, making it a preferred choice for managing type 2 diabetes and associated cardiovascular risks.
The type 2 diabetes segment, based on indication, is expected to register the highest CAGR during the forecast period. Governments and healthcare organizations in North America implement policies and programs aimed at diabetes prevention, education, and treatment.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/4167/2
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โ Higher body fat levels, especially in the abdominal area, result in insulin resistance and difficulties in controlling blood sugar levels, greatly raising the likelihood of developing type 2 diabetes.
โ Pharmaceutical companies are focusing on creating and advertising SGLT2 inhibitors to meet the rising demand from diabetic patients, especially in the obese demographic.
๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ ๐ญ๐จ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/north-america-sglt2-inhibitors-market
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
In this extremely competitive market, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market. Here are the top companies in the North America SGLT2 inhibitors market:
AstraZeneca
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
Lexicon Pharmaceuticals, Inc.
Merck & Co., Inc.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
๐๐ฒ ๐๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Cardiovascular
โข Chronic Kidney Disease (CKD)
โข Type 2 Diabetes
โข Others
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Farxiga (Dapagliflozin)
โข Inpefa (Sotagliflozin)
โข Invokana (Canagliflozin)
โข Jardiance (Empagliflozin)
โข Qtern (Dapagliflozin/Saxagliptin)
โข Other SGLT2 Inhibitors
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Hospital Pharmacies
โข Online Pharmacies
โข Retail Pharmacies
๐๐ฒ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข US
โข Canada
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, the US held the larger market share in North America in 2024. The United States has a large pharmaceutical research and development sector, leading to the quick adoption of new SGLT2 inhibitors and combination therapies. Also, during the projection period, Canada is anticipated to experience substantial growth. The Canadian government, working with provincial and territorial health authorities, has implemented various tactics to address the diabetes crisis.
o North America (U.S., Canada)
o Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
o Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
o Latin America (Brazil, Mexico, Argentina)
o Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/acute-lymphocytic-lymphoblastic-leukemia-therapeutics-market
Aesthetic Lasers Market
https://www.polarismarketresearch.com/industry-analysis/aesthetic-lasers-market
Aesthetic Medicine Market
https://www.polarismarketresearch.com/industry-analysis/aesthetic-medicine-market
Brachytherapy Market
https://www.polarismarketresearch.com/industry-analysis/brachytherapy-devices-market
Alopecia Market
https://www.polarismarketresearch.com/industry-analysis/alopecia-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America SGLT2 Inhibitors Market Expected to Reach USD 16.37 Billion by 2034, Growing at an 8.4% CAGR here
News-ID: 3743558 • Views: โฆ
More Releases from Polaris Market Research & Consulting
LTE and 5G Broadcast Market Set to Reach USD 2,447.26 Million Expanding at a 10. โฆ
LTE and 5G Broadcast Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global LTE and 5G broadcast market was estimated to be worth USD 888.39 million in 2024 and is predicted to expand to USD 2,447.26 million by 2034, with a CAGR of 10.7% from 2025 to 2034.
Market Definition:
LTE and 5G broadcast are a system for the dissemination of television and other broadcast media matter through terrestrial radio broadcastโฆ
Electrolyzer Market Predicted to Surge to US$ 323.93 Billion With an Impressive โฆ
The size of the electrolyzer market was assessed at USD 132.15 billion in 2024. With a CAGR of 9.4% over the forecast period, the market is expected to increase from USD 144.43 billion in 2025 to USD 323.93 billion by 2034.
Some of the key reasons for this growth are:
โข The increasing use of green hydrogen to reach net-zero carbon emissions is a major factor propelling the growth of the market.โฆ
Lactic Acid Market Projected to Reach USD 7.51 Billion by 2034 | CAGR: 7.8%
The global lactic acid market is set to experience substantial expansion, with projections indicating a rise from USD 3.56 billion in 2024 to USD 7.51 billion by 2034, reflecting a CAGR of 7.8%.
Market Overview
Lactic acid is a chemical the body generates when the cells disintegrate carbohydrates for energy. Muscle cells and red blood cells produce the most lactic acid, but they can emanate from any tissue in the body.โฆ
Media Monitoring Tools Market Will Surpass US$ 18.88 Billion at 12.9% CAGR Growt โฆ
The media monitoring tools market is evaluated to be at a market value of USD 5.60 billion in 2024. At a CAGR of 12.9%, the market is anticipated to grow from USD 6.32 billion in 2025 to USD 18.88 billion in 2034.
Report Scope :
In order to give a comprehensive picture of the media monitoring tools market, the study mainly focuses on current trends, important industry players, market share, revenueโฆ
More Releases for SGLT2
SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis โฆ
SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.
SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetesโฆ
SGLT2 Inhibitors Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "SGLT2 Inhibitors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of SGLT2 Inhibitors, historical and forecasted epidemiology as well as the SGLT2 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The SGLT2 Inhibitors market report provides current treatment practices, emerging drugs, SGLT2 Inhibitors market share of the individual therapies, and current and forecasted SGLT2 Inhibitors market sizeโฆ
Report Explores the SGLT2 Inhibitors Market Latest Trends and Insights by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโฆ
SGLT2 Inhibitors Market Foreseen to Grow Exponentially by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโฆ
Rising Prevalence of Diabetes Across the Globe is Expected to Drive the Global S โฆ
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโฆ
SGLT2 Inhibitors Market : Key Players and Production Information analysis with F โฆ
SGLT2 inhibitors are expected to have high consumption in the near future due to simple treatment method and relatively better results and preferred line of treatment for type II diabetes. Additionally, rising prevalence of diabetes across the globe is expected to drive the global SGLT2 inhibitors market. According to the American Diabetes Association, approximately 25.8 million people were diagnosed with diabetes in 2010 which increased to 29.1 million in 2012โฆ
